Intech Investment Management LLC Grows Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Intech Investment Management LLC increased its stake in Sabra Healthcare REIT by 8.4% during the 1st quarter, owning approximately 0.10% of the company, valued at $4.29 million.
• Sabra Healthcare REIT reported an EPS of $0.38 for the last quarter, beating estimates of $0.36, with revenues of $189.15 million, up 7.4% year-over-year.
• The firm announced a quarterly dividend of $0.30 per share, resulting in an annualized dividend yield of 6.3% and a dividend payout ratio of 157.89%.

Intech Investment Management LLC grew its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 8.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 245,415 shares of the real estate investment trust's stock after acquiring an additional 18,915 shares during the quarter. Intech Investment Management LLC owned about 0.10% of Sabra Healthcare REIT worth $4,287,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of SBRA. SVB Wealth LLC acquired a new position in shares of Sabra Healthcare REIT during the first quarter valued at about $34,000. UMB Bank n.a. increased its holdings in shares of Sabra Healthcare REIT by 379.6% during the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after acquiring an additional 1,621 shares in the last quarter. Wealth Preservation Advisors LLC acquired a new position in shares of Sabra Healthcare REIT during the first quarter valued at about $38,000. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Sabra Healthcare REIT by 61.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock valued at $49,000 after acquiring an additional 1,065 shares in the last quarter. Finally, Anchor Investment Management LLC acquired a new position in shares of Sabra Healthcare REIT during the first quarter valued at about $58,000. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Healthcare REIT Trading Down 0.4%

Sabra Healthcare REIT stock opened at $19.05 on Friday. Sabra Healthcare REIT, Inc. has a 12 month low of $15.60 and a 12 month high of $20.03. The firm has a market cap of $4.57 billion, a PE ratio of 25.07, a P/E/G ratio of 1.53 and a beta of 0.88. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. The stock's 50 day simple moving average is $18.68 and its two-hundred day simple moving average is $17.97.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. During the same quarter last year, the firm posted $0.36 EPS. The business's revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio (DPR) is 157.89%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on SBRA shares. Wells Fargo & Company upped their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Scotiabank upped their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. BMO Capital Markets upped their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research report on Monday, August 25th. Truist Financial upped their target price on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a research report on Tuesday, September 2nd. Finally, JMP Securities upped their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $20.83.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.